Improving the health of our patients through groundbreaking clinical research
The Schweiger Dermatology Group (SDG) Clinical Research Department Research Clinic is led by Dr. David Goldberg, founder of Skin, Laser and Surgery Specialist of New York and New Jersey. Dr. Goldberg brings more than 25 years of experience in conducting large multi-center clinical trials on a wide variety of cosmetic and medical devices, as well as pharmaceutical treatments. Our research team is committed to responsible research conducted under strict industry and safety standards.
Current Clinical Trials:
Study: Evaluation of Non-Treatment Mind.Px Patch for Plaque Psoriasis
Purpose: The purpose of this investigation is to evaluate the impact of Mind.Px on response to biologic treatment for Plaque Psoriasis. This is not meant to treat plaque psoriasis, but to inform the physician on the likelihood for a patient to respond to one or more biologic treatments.
Qualifications:
- Males and females, ages 18 or older
- Medical diagnosis of plaque psoriasis
Duration: Approximately 16 weeks
Location: Hackensack, NJ
Compensation: Up to $630
Interested in participating in our clinical research study? Please click here.
Study: Efficacy and Safety study of RPT193 as Monotherapy in Adults with Moderate-to-Severe Atopic Dermatitis
Purpose: This study is being done to evaluate the safety and tolerability of RPT193 in subjects with moderate to severe atopic dermatitis, also known as eczema. Investigational product will be administered as monotherapy for AD in adult patients who have had an inadequate response to topical medications for AD (e.g., corticosteroids) or who are otherwise unable to take topical medications.
Qualifications:
- Male and Females, 18 to 75 years old
- Clinical diagnosis of Atopic Dermatitis
- Documented history of inadequate response to a ≥1 month treatment with topical medications
Duration: Up to 7 months
Location: Hackensack, NJ
Compensation: Up to $650
Interested in participating in our clinical research study? Please click here.
Study: Efficacy, Safety, and Tolerability of Rocatinlimab (AMG 451) in Combination With Topical Corticosteroids and/or Topical Calcineurin Inhibitors in Adult Subjects With Moderate-to-Severe Atopic Dermatitis
Purpose: This study is being done to evaluate the safety and tolerability of Rocatinlimab (AMG 451) in subjects with moderate to severe atopic dermatitis, also known as eczema. Investigational product will be administered as monotherapy for AD in combination with topical corticosteroids/topical calcineurin inhibitor. This is a placebo-controlled, double-blind study.
Qualifications:
- Males and Females, ages 18 or older
- Clinical diagnosis of Atopic Dermatitis
- Documented history of inadequate response to topical corticosteroids within 6 months
Duration: Approximately 6 months
Location: Hackensack, NJ
Compensation: $30 per visit will be paid to the patient *once all visits are completed*
Interested in participating in our clinical research study? Please click here.
Study: Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate-to-Severe Pruritus in Adult Subjects with Atopic Dermatitis
Purpose: This study is being done to evaluate to evaluate the efficacy of 2 dose levels of oral difelikefalin as adjunct therapy to a topical corticosteroid (TCS), compared to placebo and to TCS alone, in reducing the intensity of itch after 12 weeks of treatment for moderate-to-severe pruritus in adult subjects with atopic dermatitis (AD).
Qualifications:
- Males and Females, between 18 – 80 years of age
- Clinical diagnosis of active Atopic Dermatitis
- Chronic pruritus related to Atopic Dermatitis
Duration: Approximately 4 months
Location: Hackensack, NJ
Compensation: $68 per visit will be paid to the patient *once all visits are completed*
Interested in participating in our clinical research study? Please click here.
Interested in participating in our clinical research study? Please click here.
What to expect during a clinical trial:
- Access to new investigational treatments before they are made widely available
- Financial compensation for participation
- An opportunity to contribute to the advancement of medical science through research
- Study visits conducted by a trained and dedicated research team
- Adherence to strict industry and safety standards.
- Evaluations performed by one of our certified provide
To learn more contact: Diana Aranzazu, [email protected], 609-219-5621